Topical JAK inhibitor Ruxolitinib for Vitiligo Treatment Main Article Content Brooke Rothstein Keywords Abstract Abstract not available. Disclosures: None. Copyright 2018 SKIN Article Sidebar Poster PDF Published Dec 17, 2018 DOI https://doi.org/10.25251/skin.2.supp.102 Article Details How to Cite Rothstein, B. (2018). Topical JAK inhibitor Ruxolitinib for Vitiligo Treatment. SKIN The Journal of Cutaneous Medicine, 2, S110-S111. https://doi.org/10.25251/skin.2.supp.102 More Citation Formats ACM ACS APA ABNT Chicago Harvard IEEE MLA Turabian Vancouver Issue Vol. 2 (2018): Supplemental Issue: Scientific Posters & Abstracts Presented at 2018 Fall Clinical Dermatology Conference®-Las Vegas Section Rising Derm Stars® Abstracts This work is licensed under a Creative Commons Attribution 4.0 International License. Authors transfer copyright to the publisher as part of the journal publishing agreement.All reprints are subject to the reprint policy.